About Nexus BioQuest
Nexus BioQuest is a Healthcare company based in London (United Kingdom) founded in 2022. Drug discovery services are provided for pharmaceutical research needs. Nexus BioQuest has raised $5.21 million across 3 funding rounds. Nexus BioQuest offers products and services including Drug Discovery Services, Bespoke Assay Design, and Drug Discovery Tool. Its focus areas include Biopharma Outsourcing, CRO, Drug Discovery and In Vitro Assays. Its legal entity is NEXUS BIOQUEST LIMITED. Its competitors include Metrion Biosciences, Antibody Analytics and ImmuONE; 2 of its 3 listed competitors have raised funding.
Company details
Nexus BioQuest was founded in 2022 in London, United Kingdom. Services in drug discovery are delivered by the company within the biotechnology sector. Core operations encompass target validation, compound screening, and lead optimization to aid pharmaceutical development. Clients in the life sciences industry are supported through these specialized processes, with activities based in the UK.
- Headquarters London, United Kingdom
- SectorsHealthcare
- Website nexusbioquest.com
- Social LinkedIn X Instagram
- Legal Name Nexus Bioquest Limited
- Date of Incorporation 25 May, 2022
- Jurisdiction LONDON, UNITED KINGDOM
- Total Equity Funding$5.21M (USD)
in 3 rounds
- Latest Funding Round$4.38M (USD), Seed
Jul 2022
Products & Services of Nexus BioQuest
Nexus BioQuest offers a comprehensive portfolio of products and services, including Drug Discovery Services, Bespoke Assay Design, and Drug Discovery Tool.
Comprehensive assays for target validation and candidate selection in immunology.
Tailored immunological study design for complex research questions.
Platform to select immune assays for specific therapeutic areas.
Funding Insights of Nexus BioQuest
Nexus BioQuest has successfully raised a total of $5.21M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $4.38 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5.21M
- Total Rounds 3
- Last Round Seed — $4.38M
- First Round $178,019
(Jul 2022)
All 3 funding rounds of Nexus BioQuest with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2022 | $4.38M | Seed | – | – | – |
| Jul 2022 | $643,000 | Seed | – | – | – |
| Jul 2022 | $178,019 | Seed | – | – | – |
People of Nexus BioQuest
14 people are tracked at Nexus BioQuest (2 in leadership, 12 in team).
| Name | Role | Group |
|---|---|---|
Rhiannon Jenkinson | Chief Scientific Officer | Leadership |
Danielle Clark | Program Director | Leadership |
Nat Osborne | Senior Scientist | Team |
Beth Phillips | Scientist (immunology) | Team |
Helen Tunbridge | Principal Scientist | Team |
Christopher Rice | Principal Scientist | Team |
Louise Fraser | Senior Scientist | Team |
Sally Woodman | Principal Scientist | Team |
Silvia Rosini | Principal Scientist | Team |
Francis Hughes | Scientist | Team |
Helen Ludlow | Senior Scientist | Team |
Agata Krygowska | Lead Senior Scientist | Team |
Ella Hearn | Senior Scientist | Team |
Pauline le Vu | Lead Senior Scientist | Team |
Complete people profiles for Nexus BioQuest
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Nexus BioQuest
3 dated milestones of Nexus BioQuest, from founding to its latest funding, stage changes and deals.
- Founded Nexus BioQuest is founded.
- Funding First funding round of $178K.
- Funding Latest funding round, Seed, of $4.4M.
Competitors of Nexus BioQuest
Nexus BioQuest has 3 listed competitors in our database, 2 of them funded. They include Metrion Biosciences, Antibody Analytics and ImmuONE.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| metrionbiosciences.com | 2015 | Cambridge, United Kingdom | $8.44M | Ion channel screening and cardiac safety profiling services are provided. | ||
| antibodyanalytics.com | 2015 | Lanark, United Kingdom | 60 | Antibody analytics and characterization services are provided. | ||
| immuone.com | 2019 | Hatfield, United Kingdom | $3.2M | 8 | Innovative inhalation safety solutions are developed by ImmuONE. |
Detailed competitors of Nexus BioQuest
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Nexus BioQuest
The website of Nexus BioQuest (nexusbioquest.com) receives about 2.5K visits a month.
- Monthly visits2.5K
▲ 180.6% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Nexus Bioquest
Complete news archive for Nexus BioQuest
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nexus BioQuest
Nexus BioQuest was founded in 2022.
Nexus BioQuest is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Nexus BioQuest is a funded company, having raised a total of $5.21M across 3 funding rounds to date. The company's 1st funding round was a Seed of $178.02K, raised on Jul 2022.
Nexus BioQuest was founded in 2022 in London, United Kingdom. Services in drug discovery are delivered by the company within the biotechnology sector. Core operations encompass target validation, compound screening, and lead optimization to aid pharmaceutical development. Clients in the life sciences industry are supported through these specialized processes, with activities based in the UK.
Nexus BioQuest's top competitors include Metrion Biosciences, ImmuONE and Antibody Analytics.
Nexus BioQuest offers Drug Discovery Services, Bespoke Assay Design, and Drug Discovery Tool.
Nexus BioQuest operates through Nexus Bioquest Limited.